Maspero Marianna, Heilman Jaclyn, Otero Piñeiro Ana, Steele Scott R, Hull Tracy L
Department of Colon and Rectal Surgery, Digestive Disease and Surgery Institute, Cleveland Clinic Foundation, OH. Electronic address: http://www.twitter.com/MariannaMaspero.
General Surgery, Jefferson Health-Abington, Abington, PA.
Surgery. 2023 Feb;173(2):312-321. doi: 10.1016/j.surg.2022.10.022. Epub 2022 Nov 18.
Perineal hernias are rare, underreported and poorly studied complications of extensive pelvic surgeries. Their management is challenging, with currently no treatment algorithm available.
MEDLINE, EMBASE, Cochrane Library, and Web of Science databases were searched. Studies comprising at least 3 patients who underwent surgical perineal hernia repair were included. The primary outcome was perineal hernia recurrence. The secondary outcomes were overall complications and surgical site occurrences.
Twenty-nine studies were included, comprising 325 patients undergoing 347 repairs. Overall complications were 33% (95% confidence interval 24%-43%) in the entire cohort, 31% (19%-44%) after perineal repair, 39% (14%-67%) after abdominal repair, and 36% (19%-53%) after mesh repair (20% with biological, 46% with synthetic mesh). The surgical site occurrence rate was 18% (8%-29%). The overall recurrence rate was 22% (15%-29%). Recurrence after perineal repair was 19% (10%-29%): 20% with mesh (25% with biological, 19% with synthetic), 24% with primary repair, and 39% with flap repair. Recurrence after an abdominal repair was 18% (11%-26%): 16% with laparoscopic, 12% with open, 16% with mesh (24% with biological, 16% with synthetic), 30% with primary, and 25% with flap repair. No significant differences could be found in the meta-analysis regarding overall complications and recurrence.
Synthetic mesh repair seems to be associated with a lower recurrence rate than other techniques, especially after an abdominal approach. The perineal and abdominal approaches appear to be safe, with similar recurrence rates. The combined approach seems promising, but more evidence is needed.
会阴疝是广泛盆腔手术罕见、报道不足且研究较少的并发症。其治疗具有挑战性,目前尚无可用的治疗方案。
检索了MEDLINE、EMBASE、Cochrane图书馆和科学网数据库。纳入至少3例接受手术治疗会阴疝修补术的患者的研究。主要结局是会阴疝复发。次要结局是总体并发症和手术部位事件。
纳入29项研究,包括325例患者接受347次修补术。整个队列的总体并发症为33%(95%置信区间24%-43%),会阴修补术后为31%(19%-44%),腹部修补术后为39%(14%-67%),网片修补术后为36%(19%-53%)(生物网片为20%,合成网片为46%)。手术部位事件发生率为18%(8%-29%)。总体复发率为22%(15%-29%)。会阴修补术后复发率为19%(10%-29%):网片修补为20%(生物网片为25%,合成网片为19%),一期修补为24%,皮瓣修补为39%。腹部修补术后复发率为18%(11%-26%):腹腔镜修补为16%,开放修补为12%,网片修补为16%(生物网片为24%,合成网片为16%),一期修补为30%,皮瓣修补为25%。荟萃分析在总体并发症和复发方面未发现显著差异。
合成网片修补术似乎比其他技术的复发率更低,尤其是在腹部入路后。会阴和腹部入路似乎是安全的,复发率相似。联合入路似乎很有前景,但需要更多证据。